You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 昂利康(002940.SZ)大漲近9% 擬與海昶生物就“HC008”研發生產開展合作
格隆匯 05-31 14:23
格隆匯5月31日丨昂利康(002940.SZ)大漲近9%,報33.49元,股價創近一個月新高,總市值32億元。昂利康公佈,2021 年5月28日,公司與浙江海昶生物醫藥技術有限公司就"HC008"(一款酰胺類局部麻醉藥的複雜注射劑仿製藥,尚處於研發階段)的合作開發項目及成立合資公司簽訂《海昶生物與昂利康關於"HC008"合作項目之合作備忘錄》。本次備忘錄的簽署意在為雙方後續組建研發及商業化標的藥品的項目公司達成初步合作意向,是公司在複雜製劑合同生產(CMO)業務上的嘗試,有助於提升公司在藥品製造領域的競爭優勢,進而提升公司未來核心競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account